中华预防医学杂志
中華預防醫學雜誌
중화예방의학잡지
Chinese Journal of Preventive Medicine
2015年
9期
766-770
,共5页
缪宁%张国民%郑徽%吴振华%孙校金%王锋%王富珍%崔富强%李黎
繆寧%張國民%鄭徽%吳振華%孫校金%王鋒%王富珍%崔富彊%李黎
무저%장국민%정휘%오진화%손교금%왕봉%왕부진%최부강%리려
肝炎,乙型%哨点监测%人口统计学
肝炎,乙型%哨點鑑測%人口統計學
간염,을형%초점감측%인구통계학
Hepatitis B%Sentinel surveillance%Demography
目的:分析中国乙型肝炎监测试点县(区)附卡信息及疑似急性乙型肝炎病例标本乙型肝炎核心抗体(抗-HBc) IgM复核结果,了解全国乙型肝炎监测试点情况。方法选取2013年中国200个乙型肝炎监测试点县(区)全国法定传染病报告系统(NNDRS)中报告的乙型肝炎病例作为研究对象,共63641例。所有报告乙型肝炎病例均填写附卡信息。对疑似急性乙型肝炎病例采集静脉血5 ml,统一进行抗-HBc IgM检测;结合报告卡附卡信息及抗-HBc IgM检测结果,对疑似急性乙型肝炎病例进行复核诊断。结果63641例乙型肝炎病例中附卡填写乙型肝炎表面抗原(HBsAg)阳性时间6个月内阴转阳者1723例,其中报告为慢性乙型肝炎735例,占42.66%;抗-HBc IgM检测阳性者4582例,其中报告为急性乙型肝炎2436例,占53.16%,报告为慢性乙型肝炎1829例,占39.92%;肝穿刺和恢复期血清变化的有效填写数分别是579例和4961例,分别占总报告病例数的0.91%和7.80%。对4302例疑似急性乙型肝炎进行重新复核诊断,最终诊断为急性乙型肝炎1197例,占27.82%,慢性乙型肝炎2590例,占60.20%。结论临床医生未能充分利用报告卡附卡信息对乙型肝炎病例进行诊断;对抗-HBc IgM阳性的疑似急性乙型肝炎病例应重视随访,运用HBsAg指标变化进一步区分急慢性乙型肝炎。
目的:分析中國乙型肝炎鑑測試點縣(區)附卡信息及疑似急性乙型肝炎病例標本乙型肝炎覈心抗體(抗-HBc) IgM複覈結果,瞭解全國乙型肝炎鑑測試點情況。方法選取2013年中國200箇乙型肝炎鑑測試點縣(區)全國法定傳染病報告繫統(NNDRS)中報告的乙型肝炎病例作為研究對象,共63641例。所有報告乙型肝炎病例均填寫附卡信息。對疑似急性乙型肝炎病例採集靜脈血5 ml,統一進行抗-HBc IgM檢測;結閤報告卡附卡信息及抗-HBc IgM檢測結果,對疑似急性乙型肝炎病例進行複覈診斷。結果63641例乙型肝炎病例中附卡填寫乙型肝炎錶麵抗原(HBsAg)暘性時間6箇月內陰轉暘者1723例,其中報告為慢性乙型肝炎735例,佔42.66%;抗-HBc IgM檢測暘性者4582例,其中報告為急性乙型肝炎2436例,佔53.16%,報告為慢性乙型肝炎1829例,佔39.92%;肝穿刺和恢複期血清變化的有效填寫數分彆是579例和4961例,分彆佔總報告病例數的0.91%和7.80%。對4302例疑似急性乙型肝炎進行重新複覈診斷,最終診斷為急性乙型肝炎1197例,佔27.82%,慢性乙型肝炎2590例,佔60.20%。結論臨床醫生未能充分利用報告卡附卡信息對乙型肝炎病例進行診斷;對抗-HBc IgM暘性的疑似急性乙型肝炎病例應重視隨訪,運用HBsAg指標變化進一步區分急慢性乙型肝炎。
목적:분석중국을형간염감측시점현(구)부잡신식급의사급성을형간염병례표본을형간염핵심항체(항-HBc) IgM복핵결과,료해전국을형간염감측시점정황。방법선취2013년중국200개을형간염감측시점현(구)전국법정전염병보고계통(NNDRS)중보고적을형간염병례작위연구대상,공63641례。소유보고을형간염병례균전사부잡신식。대의사급성을형간염병례채집정맥혈5 ml,통일진행항-HBc IgM검측;결합보고잡부잡신식급항-HBc IgM검측결과,대의사급성을형간염병례진행복핵진단。결과63641례을형간염병례중부잡전사을형간염표면항원(HBsAg)양성시간6개월내음전양자1723례,기중보고위만성을형간염735례,점42.66%;항-HBc IgM검측양성자4582례,기중보고위급성을형간염2436례,점53.16%,보고위만성을형간염1829례,점39.92%;간천자화회복기혈청변화적유효전사수분별시579례화4961례,분별점총보고병례수적0.91%화7.80%。대4302례의사급성을형간염진행중신복핵진단,최종진단위급성을형간염1197례,점27.82%,만성을형간염2590례,점60.20%。결론림상의생미능충분이용보고잡부잡신식대을형간염병례진행진단;대항-HBc IgM양성적의사급성을형간염병례응중시수방,운용HBsAg지표변화진일보구분급만성을형간염。
Objective To analyze the information of the supplementary card for hepatitis B and the laboratory confirmed result of immunoglobulin M antibody to hepatitis B virus (HBV) Core Antigen (anti-HBc IgM) for the suspected acute hepatitis B to evaluate the hepatitis B report data on pilot surveillance. Methods 200 counties were established in China for hepatitis B pilot surveillance and 63 641 cases were reported. We added a supplementary card in National Notificable Disease Reporting System (NNDRS) and all the reported hepatitis B cases in NNDRS were required to fill the supplementary card. Venous blood 5 ml was collected and a confirmed test of anti-HBc IgM was made for suspected acute hepatitis B. We made confirmed diagnosis for the suspected acute hepatitis B according to the supplementary card information of the reporting card and the confirmed test result of anti-HBc IgM. Results 63 641 hepatitis B cases were reported in 200 hepatitis B pilot surveillance counties in 2013. Among 1 723 cases which were filled with the HBsAg positive within six months in supplementary card, 735 cases were reported as chronic hepatitis B, the proportion was 42.66%. Among 4 582 cases which were filled with anti-HBc IgM positive in supplementary card, 2 436 cases were reported as acute hepatitis B , the proportion was 53.16%. 1 829 cases were reported as chronic hepatitis B, the proportion was 39.92%. The validity cases of the information for liver puncture and the HBV surface antigen (HBsAg) transform during the recovery period in supplementary cards for all the reporting cases were 579 and 4 961,and the rate were 0.91% and 7.80%, respectively. 4 302 suspected acute cases were made confirmed diagnosis, and 1 197 cases (27.82%) were confirmed acute and 2 590 cases (60.20%) were confirmed chronic. Conclusion <br> Clinical doctors failed to make full use of the information of supplementary cards to make classification diagnose for hepatitis B. Suspected acute hepatitis B with anti-HBc IgM positive should be pay attention to follow up and further distinguish acute or chronic hepatitis B according to the HBsAg transform.